Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

Research output: Contribution to journalArticlepeer-review

13 Scopus citations
Original languageEnglish
Article numbere227657
JournalJAMA Network Open
Volume5
Issue number4
DOIs
StatePublished - 1 Apr 2022

ASJC Scopus subject areas

  • General Medicine

Cite this